Lunai Bioworks (LNAI) Cash from Operations (2011 - 2026)
Lunai Bioworks (LNAI) posted quarterly Cash from Operations of 1026856.0 for Q1 2026, up 30.97% year-over-year from 784064.47 in Q1 2025, and up 4.14% quarter-over-quarter from 1071213.0 in Q4 2025.
Lunai Bioworks (LNAI) Cash from Operations (2011 - 2026) Analysis & Trends
Lunai Bioworks' Cash from Operations history runs 16 years deep, the most recent figure standing at 1026856.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 30.97% year-over-year to 1026856.0; the TTM figure through Mar 2026 stood at 5258315.0 (up 37.97% YoY), while the FY2025 annual figure was 7874647.0, up 28.23% from the prior year.
- Cash from Operations for Q1 2026 stood at 1026856.0, up from 1071213.0 in the prior quarter.
- The five-year high for Cash from Operations was 1026856.0 in Q1 2026, with the low at 3551471.0 in Q4 2022.
- The 5-year median for Cash from Operations is 2559724.0 (2024), against an average of 2347234.71.
- Peak annual rise in Cash from Operations reached 76.59% in 2022, while the deepest fall reached 19.47% in 2022.
- Lunai Bioworks' Cash from Operations stood at 3551471.0 in 2022, then grew by 11.4% to 3146623.0 in 2023, then advanced by 18.65% to 2559724.0 in 2024, then surged by 58.15% to 1071213.0 in 2025, then increased by 4.14% to 1026856.0 in 2026.
- Business Quant data shows LNAI's Cash from Operations at 1026856.0 in Q1 2026, 1071213.0 in Q4 2025, and 1349110.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.75 Bn | 130.90 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.96 Bn | 77.96 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.33 Bn | 51.19 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.56 Bn | 28.25 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | 728.46 Mn |
| 10 | Lunai Bioworks | 6.78 Mn | 3.62 Mn | 20,942.00 | -1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.03 Mn |
| Mar 31, 2026 | -1.03 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Mar 31, 2025 | -1.49 Mn |
| Mar 31, 2025 | -1.49 Mn |
| Dec 31, 2024 | -2.56 Mn |
| Dec 31, 2024 | -2.56 Mn |
| Sep 30, 2024 | -2.02 Mn |
| Sep 30, 2024 | -2.02 Mn |
| Jun 30, 2024 | -2.41 Mn |
| Jun 30, 2024 | -2.41 Mn |
| Mar 31, 2024 | -2.63 Mn |
| Mar 31, 2024 | -2.63 Mn |
| Dec 31, 2023 | -3.15 Mn |
| Dec 31, 2023 | -3.15 Mn |